The development of IgY(ΔFc) antibody based neurotoxin antivenoms and the study on their neutralization efficacies

Clinical Toxicology

Volumn 46, Issue 6, 2008, Pages 539-544

  Chiou, Victor Y Neng ^a  

^a Good Biotech Corp   (Taiwan)

Author keywords

Antivenom; Duck IgY( Fc); Fab'; Neurotoxin; Neutralization

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN Y; IMMUNOGLOBULIN Y ANTIBODY; NEUROTOXIN; SNAKE VENOM; SNAKE VENOM ANTISERUM; ANTIBODY; BUNGAROTOXIN; IMMUNOGLOBULIN; VENOM ANTISERUM;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DUCK; EGG YOLK; ENVENOMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IN VIVO STUDY; LETHAL DOSE; MORTALITY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; SERODIAGNOSIS; SURVIVAL RATE; ANIMAL; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LD 50; SNAKEBITE; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

ANAS; AVES; BUNGARUS FASCIATUS; MAMMALIA; MUS; OVIS;

ANIMALS; ANTIBODIES; ANTIVENINS; BUNGAROTOXINS; COBRA VENOMS; DUCKS; EGG YOLK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULINS; INJECTIONS, SUBCUTANEOUS; LETHAL DOSE 50; MICE; MICE, INBRED ICR; NEUTRALIZATION TESTS; SNAKE BITES; SURVIVAL ANALYSIS;

EID: 46249101567     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701771973     Document Type: Article

References (20)

1. Juckett G, Hancox JG. Venomous snakebites in the United States: management eview and update. Am Fam Physician 2002; 65(7):1367-74.
2. Pope CG. The action of proteolytic enzymes on the antitoxins and proteins in immune sera. I. True digestion of the proteins. Br J Exp Pathol 1939; 20: 132-49.
3. Karlson-Stiber C, Persson H, Heath A, Smith D, Al-Abdulla H, Sjostrom L. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming. J Intern Med 1997; 241:53-58.
4. Baur X, Chen Z, Rozynek P, Duser M, Raulf-Heimsoth M. Cross-reacting IgE antibodies recognizing latex allergens, including Hev b 1, as well as papain. Allergy 1995; 50:604-609.
5. Quarre JP, Lecomte J, Lauwers D, Gilbert P, Thiriaux J. Allergy to latex and papain. J Allergy Clin Immunol 1995; 95(4):922.
6. Devi CM, Bai MV, Krishnan LK. Development of viper-venom antibodies in chicken egg yolk and assay of their antigen binding capacity. Toxicon 2002; 40:857-861.
7. Thalley BS, Carroll SB. Rattlesnake and scorpion antivenoms from the egg yolks of immunized hens. Bio/Technology 1990; 8:934-938.
8. Girard F, Batisson I, Martinez G, Breton C, Harel J, Fairbrother JM. Use of virulence factor-specific egg yolk-derived immunoglobulins as a promising alternative to antibiotics for prevention of attaching and effacing Escherichia coli infections. FEMS Immunol Med Microbiol 2006; 46(3):340-350.
9. Schade R, Calzado EG, Sarmiento R, Chacana PA, Porankiewicz-Asplund J, Terzolo HR. Chicken egg yolk antibodies (IgY-technology): a review of progress in production and use in research and human and veterinary medicine. Altern Lab Anim 2005; 33(2):129-54.
10. Akita EM, Nakai S. Comparison of four purification methods for the production of immunoglobulins from eggs laid by hens immunized with an enterotoxigenic E. coli strain. J Immunol. Meth 1993; 160:207-214.
11. Akita EM, Nakai S. Production and purification of Fab' fragments from chicken egg yolk immunoglobulin Y (IgY). J Immunol Meth 1993; 162:155-164.
12. Higgins DA, Warr GW. Duck Immunoglobulins: Structure, Functions and Molecular Genetics. Avian Pathology 1993; 22(2):211-236.
13. Chiou V. Duck antibodies for IVD applications: A naturally existing analog to mammalian antibodies offers an alternative with broad applications. IVD Technology 2002; 8(3):31-35.
14. Tsen YC, Kao GY, Chang CL, Lai FY, Huang CH, Ouyang S, Yu MH, Wang CP, Chiou YN. Evaluation and validation of a duck IgY antibody-based immunoassay for high-sensitivity C-reactive protein: avian antibody application in clinical diagnostics. Clin. Chem 2003; 49(5):810-813.
15. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoint. Am. J. Hyg 1938; 27:493-497.
16. Theakston RDG, Warrell DA, Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 2003; 41:541-557.
17. Chulasugandha P. Snake antivenoms: heterologous and polyclonal antisera. Journal of Toxicology- Toxin Reviews 2003; 22(1):1-14.
18. Gutiérrez JM, León G, Lomonte B. Pharmacokinetic- pharmacodynamic relationships of immunoglobulin therapy for envenomation. Clin Pharmacokinet 2003; 42(8):721-741.
19. Brunda G, Sashidhar RB, Sarin RK. Use of egg yolk antibody (IgY) as an immunoanalytical tool in the detection of Indian cobra (Naja naja naja) venom in biological samples of forensic origin. Toxicon 2006; 48:183-194.
20. Madaras F, Mirtschin PJ. Antivenom development in Australia. Toxin Reviews 2005; 24:79-94.